2019
DOI: 10.1016/j.bmc.2018.12.043
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
18
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 43 publications
2
18
0
Order By: Relevance
“…The spectral data matched with structural attributes for each individual compound are presented in the Supplementary Data File. We previously confirmed the structure of CP-155, CP-209 and CP-262-F2 by single-crystal X-ray diffraction [28].…”
Section: Synthesis Of Di-and Triconjugated Coumaperine Derivativessupporting
confidence: 63%
See 4 more Smart Citations
“…The spectral data matched with structural attributes for each individual compound are presented in the Supplementary Data File. We previously confirmed the structure of CP-155, CP-209 and CP-262-F2 by single-crystal X-ray diffraction [28].…”
Section: Synthesis Of Di-and Triconjugated Coumaperine Derivativessupporting
confidence: 63%
“…Although CP is characterized by important pharmacophores such as the Michael acceptor, phenolic and amide moieties, its bioactivity has not been properly explored, probably due to its low bioavailability and long synthetic protocols. Recently, we reported a simple and a robust methodology for the synthesis of CP and its derivatives [28,29]. Following that synthetic process, CP derivatives depicted in Figures 2-4, were synthesized, and characterized for the present study.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations